Who is actually qualified to make a medical claim?

TL;DR

• A medical claim deserves more than a confident title: the speaker’s role, the evidence, the exact wording, the patient context, and any commercial interest all matter.¹
• An endocrinologist may bring relevant specialist knowledge, but a specialty label alone cannot supply an assessment of a particular person or prove a product statement.²
• A clinic name identifies a facility, while a reseller or influencer may also be speaking from a commercial position rather than a clinical one.³
• Philippine rules limit health-product promotional claims, and WHO says such claims should be accurate, balanced, current, and capable of substantiation.⁴

For Filipino readers, the same health statement may arrive through a clinic page, a reseller’s chat, a doctor’s reel, or a friend’s shared post. Those formats can look equally polished on a phone. They do not carry equal authority.¹ The useful question is not simply, “Who said it?” Ask what is being claimed and what gives the speaker grounds to say it.⁵

Start with the claim, not the job title

A medical claim links a product or action to a health effect, a safety conclusion, or a scientific conclusion.⁵ “This worked for me” is a personal report, while “this works for people like you” makes a broader claim.⁵ The second statement needs evidence that matches its scope.⁴

Titles still matter, but they answer only one question: what training or role might the speaker have?² They do not reveal whether the person assessed you, read the whole study, stayed within the findings, or has a financial interest.¹ A useful first pass therefore separates five things: speaker, statement, evidence, context, and incentive.¹ That method works across a consultation room, a clinic account, a sales message, and a social feed.¹

For readers comparing nearby catalog topics, the semaglutide card below opens its live catalog details.

What a specialist can add

An endocrinologist’s specialty can signal relevant knowledge for claims within that field.² Yet the strongest clinical position also depends on a licensed medical role and enough information about the person asking the question.⁶ Philippine telemedicine guidance says the patient-physician relationship should rest on medical history and an examination suited to the circumstances.⁶

That distinction separates general education from personal medical judgment.⁶ A sound study explanation should state what was measured, who joined, and what limits apply.⁴ A conclusion about one person needs clinical context that a public post usually lacks.⁶ Credentials are needed for some tasks, but they are not a blank check for every statement.²

The fairest test is specific: Is this speaker working inside the subject, evidence, and patient context that the claim requires?¹

A clinic name is not a credential

Philippine guidance defines a physician and a health facility as separate things.³ A clinic can organize records, staff, appointments, and services, but the clinic name does not tell you who wrote a particular statement.³ Philippine FDA rules separately name owners, distributors, advertisers, and agents as responsible actors in public promotion.⁷

Before treating a clinic post as medical guidance, identify the accountable speaker and the statement’s purpose.¹ Ask whether the post is broad education, an individualized conclusion, or product promotion.⁵ Then look for the named clinician’s role, the evidence behind the words, and the boundaries of the claim.¹

This is not cynicism about clinics.³ It is a basic separation between an institution’s brand and a professional’s clinical judgment.³

A reseller speaks from a commercial role

A reseller may know ordering systems, customer questions, or product descriptions, but that experience is not a clinical assessment.⁷ Knowing the sales process cannot show that a health statement fits a person or a study.⁴ The sales role also creates an interest in the transaction, which readers should identify rather than shame.¹

Philippine FDA rules are especially useful here.⁸ They cover health-product marketing addressed to the public in any form of media.⁸ They also restrict promotional claims to approved labeling, packaging, or other FDA approval.⁸ Manufacturers, owners, distributors, advertisers, and their agents share responsibilities under those rules.⁷

So a reseller’s confidence, repeated customer story, or access to a clinic contact does not widen the permitted claim.⁸ The exact words still need regulatory scope and evidence.¹

An influencer may teach, persuade, or sell

“Influencer” describes reach and audience relationship, not a medical qualification.¹ A creator may speak from a health role, personal experience, or a commercial position, so readers should identify which role supports the claim.¹ Those roles can overlap, so the bio line alone is an incomplete guide.¹

A 2025 study examined 96 full-length and 93 short English-language YouTube videos found through semaglutide-related searches.⁹ Full-length videos from verified health sources scored higher on two quality tools than other full-length videos.¹⁰ Yet the sampled videos still omitted several safety topics selected by the researchers.¹⁰ The authors treated the sample as platform-, language-, and search-specific rather than a map of every post online.⁹

The lesson is modest. A health credential can be a useful signal, but each claim still needs checking.¹⁰ Views, warmth, certainty, and a verified badge cannot replace solid support.⁴

Evidence has to fit the sentence

WHO says medicine promotion should be accurate, truthful, useful, balanced, current, and backed by evidence.⁴ “Balanced” matters because an accurate detail can still mislead when key limits are left out.⁴ A speaker should name the type of evidence and keep the conclusion inside what it measured.⁴

For research, look for the population, design, comparison, outcome, and time period.¹ For an individualized conclusion, add medical history and an appropriate examination.⁶ For a promotional statement in the Philippines, add the relevant FDA scope.⁸ These are different gates, and one cannot stand in for another.¹

A paper citation is therefore a starting point, not decoration.⁴ Open it and find the actual result. Check whether the speaker changed a group finding into a promise about you.¹

For readers comparing nearby catalog topics, the tirzepatide card below opens its live catalog details.

Follow the money and check the record

A money interest does not automatically make a statement false, but hiding it removes information readers need.¹¹ A review of 17 studies found that conflict reporting in social-media health messages ranged from 0% to 60% and was mostly low.¹¹ The studies varied enough that the authors did not combine them into one estimate.¹² That range should not be treated as a Filipino rate.¹²

For Philippine product records, the FDA Verification Portal provides searchable fields such as registration number, names, classification, manufacturer, and record dates.¹ A portal entry can confirm listed details, but it cannot decide whether a claim fits your health context.¹

The DOH has also warned about fabricated testimonials, fake expert endorsements, and exaggerated health claims.¹³ Its warning directs readers toward official DOH accounts when an endorsement appears questionable.¹³ Verification works best in layers: person, evidence, regulatory record, and incentive.¹

Bottom line

No single label wins every medical-claim question.¹ An endocrinologist may bring relevant specialist knowledge, but individualized judgment still needs patient context.⁶ A clinic is a facility, not proof of who authored a post.³ A reseller carries a commercial role, while an influencer label describes reach rather than clinical authority.¹ Across all four, the reliable test is the same: identify the speaker, read the exact statement, match it to the evidence, check the Philippine regulatory scope when promotion is involved, and look for financial interests.¹ Credibility is built claim by claim, not borrowed from a logo, follower count, white coat, or confident tone.⁴

This article is educational research context, not medical advice. Catalog links are neutral references and do not imply a treatment or human-use recommendation.

Frequently asked questions

Is an endocrinologist always the best person to ask?

An endocrinologist may have relevant specialty knowledge, but the right professional depends on the exact question.² A personal conclusion also needs medical history and an appropriate examination.⁶ Check whether the clinician’s role, subject knowledge, and patient context match the claim.¹

Does a clinic page count as medical advice?

Not automatically. Philippine guidance treats a physician and a health facility as separate categories.³ Public clinic content may also fall within Philippine rules when it promotes a health product.⁸ Identify the author, purpose, evidence, and whether the words address the public or a particular patient.¹

Can a reseller repeat what a doctor said?

Repeating a statement does not transfer the doctor’s clinical role to the reseller.⁷ For public health-product promotion, Philippine FDA rules still limit claims to approved scope.⁸ Readers should ask for the original, accountable source and check whether the repeated wording became broader or more certain.¹

What makes an influencer’s health post more credible?

Useful signals include a verifiable professional role, a clearly named source, accurate limits, and a visible financial disclosure.¹ In one semaglutide YouTube study, verified health-source videos scored better as a group, but important omissions remained across the sample.¹⁰ Every statement still needs review.⁴

Is a personal testimonial a medical claim?

A testimonial can accurately describe one person’s reported experience without proving a general effect.⁵ It becomes a broader medical claim when the story is used to predict what will happen to other people.⁵ Philippine DOH guidance flags fabricated testimonials and exaggerated health claims as warning signs.¹³

How can I check a product-related claim in the Philippines?

First separate the exact claim from the product name.¹ The Philippine FDA Verification Portal can confirm listed regulatory fields, while the approved scope governs public promotional claims.⁸ That check does not replace a clinician’s assessment of an individual, which requires appropriate patient context.⁶

Sources

Footnotes

1. The Rules and Regulations Implementing Republic Act No. 9711 — The Food and Drug Administration Act of 2009; Guidelines on the Implementation of Telemedicine in the Delivery of Health Services; Ethical criteria for medicinal drug promotion; Conflict of interest and funding in health communication on social media: a systematic review; FDA Verification Portal — Drug Products. Editorial synthesis of Philippine clinical and promotional guidance, WHO claim criteria, conflict-of-interest research, and the Philippine FDA verification fields. The checklist is an educational screening tool, not a legal determination or a substitute for clinical consultation. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷ ↩¹⁸ ↩¹⁹ ↩²⁰ ↩²¹ ↩²² ↩²³ ↩²⁴ ↩²⁵ ↩²⁶ ↩²⁷

2. The Rules and Regulations Implementing Republic Act No. 9711 — The Food and Drug Administration Act of 2009; Guidelines on the Implementation of Telemedicine in the Delivery of Health Services; Ethical criteria for medicinal drug promotion. Synthesis separating professional role, clinical context, substantiation, and Philippine promotional rules. This does not diminish specialist training; it identifies the other elements needed to evaluate a particular claim. ↩ ↩² ↩³ ↩⁴ ↩⁵

3. Guidelines on the Implementation of Telemedicine in the Delivery of Health Services. Definitions in Philippine guidance for remote delivery of health services. The guidance was written for telemedicine and does not certify any named physician, specialty, or clinic. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

4. Ethical criteria for medicinal drug promotion. WHO ethical criteria for medicinal-drug promotion. The WHO criteria are ethical guidance; national law and regulation determine legal requirements. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹

5. The Rules and Regulations Implementing Republic Act No. 9711 — The Food and Drug Administration Act of 2009; Ethical criteria for medicinal drug promotion. Reader-facing synthesis of the Philippine FDA rules for therapeutic or scientific claims and WHO criteria for medicinal-drug promotion. This is a plain-language working definition, not a new statutory definition or a ruling on any specific statement. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

6. Guidelines on the Implementation of Telemedicine in the Delivery of Health Services. Principles governing telemedicine in the Philippines. The document does not imply that every question needs the same type of examination or that a public educational statement is a consultation. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

7. The Rules and Regulations Implementing Republic Act No. 9711 — The Food and Drug Administration Act of 2009. Article V, section on responsibilities for advertising, promotion, sponsorship, and other marketing activities. Responsibility for compliant promotion is not the same as clinical qualification to assess an individual. ↩ ↩² ↩³ ↩⁴

8. The Rules and Regulations Implementing Republic Act No. 9711 — The Food and Drug Administration Act of 2009. Article V of the implementing rules for Republic Act No. 9711. The rule concerns regulated health-product promotion; it does not turn every casual health discussion into product advertising. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

9. Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos. Cross-sectional mixed-methods content analysis of YouTube search results. The sample was platform-, language-, search-term-, and time-specific and does not represent every social-media post. ↩ ↩²

10. Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos. Comparison using Global Quality Score, Modified DISCERN, and a custom checklist. Channel status was associated with group-level scores; it did not validate every sentence, creator, or video. ↩ ↩² ↩³ ↩⁴

11. Conflict of interest and funding in health communication on social media: a systematic review. Systematic review of studies published through the review's search dates in 2022. The included studies covered different platforms, professions, topics, and methods. ↩ ↩²

12. Conflict of interest and funding in health communication on social media: a systematic review. Methodological limitation reported by the systematic-review authors. The reported range should not be read as one prevalence estimate for Filipino creators or any single platform. ↩ ↩²

13. On Fake DOH Facebook Page Endorsing False Health Claims and Products. DOH response to a fake Facebook page using the department's identity and a health-product claim. The warning concerned one specific incident and does not establish that every testimonial or endorsement is false. ↩ ↩² ↩³